News
Search EMA's news announcements
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
We are currently carrying out work to improve the usability of our search function. This may cause search results to be incomplete. We anticipate this issue will be resolved in the coming hours. To fetch data from this website via automated systems, please use our JSON data files.
13 new medicines recommended for approval; another 8 medicines recommended for extension of their therapeutic indications
The new propellant in Trixeo Aerosphere and Riltrava Aerosphere has lower global warming potential
Injectable lenacapavir, administered twice yearly, is highly effective at preventing HIV
Vaccine to be used only when there is a significant chikungunya risk and after careful consideration of the benefits and risks
Aqneursa significantly improves neurological signs, symptoms and functioning
Sabine Scherer begins her three-year mandate in September 2025
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting
Ixchiq: temporary restriction on vaccinating people 65 years and older to be lifted
Vaccine to be used only when there is a significant chikungunya risk and after careful consideration of the benefits and risks
EMA and HMA recommendations to address vulnerabilities in the supply of critical medicines used during pregnancy